NCT04090567 2026-03-05Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerM.D. Anderson Cancer CenterPhase 2 Recruiting60 enrolled
NCT03740893 2025-08-11PHOENIXInstitute of Cancer Research, United KingdomPhase 2 Recruiting119 enrolled